171 related articles for article (PubMed ID: 20030210)
1. [Regulation, structure and function of brain aquaporin].
Masato Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):786-8. PubMed ID: 20030210
[TBL] [Abstract][Full Text] [Related]
2. Regulation of water permeability through aquaporin-4.
Yukutake Y; Yasui M
Neuroscience; 2010 Jul; 168(4):885-91. PubMed ID: 19850109
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.
Rosito S; Nicchia GP; Palazzo C; Lia A; Buccoliero C; Pisani F; Svelto M; Trojano M; Frigeri A
J Cell Mol Med; 2018 Feb; 22(2):1236-1246. PubMed ID: 29055082
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
[TBL] [Abstract][Full Text] [Related]
6. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
8. [Roles of Aquaporins in Brain Disorders].
Yasui M
Brain Nerve; 2015 Jun; 67(6):733-8. PubMed ID: 26062588
[TBL] [Abstract][Full Text] [Related]
9. Role of the H-bond between L53 and T56 for Aquaporin-4 epitope in Neuromyelitis Optica.
Pisani F; Simone L; Gargano CD; De Bellis M; Cibelli A; Mola MG; Catacchio G; Frigeri A; Svelto M; Nicchia GP
Biochim Biophys Acta Biomembr; 2017 Mar; 1859(3):368-376. PubMed ID: 28027883
[TBL] [Abstract][Full Text] [Related]
10. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
[TBL] [Abstract][Full Text] [Related]
11. Comparative molecular dynamics study of neuromyelitis optica-immunoglobulin G binding to aquaporin-4 extracellular domains.
Alberga D; Trisciuzzi D; Lattanzi G; Bennett JL; Verkman AS; Mangiatordi GF; Nicolotti O
Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1326-1334. PubMed ID: 28477975
[TBL] [Abstract][Full Text] [Related]
12. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
14. Neurological autoimmunity targeting aquaporin-4.
Hinson SR; McKeon A; Lennon VA
Neuroscience; 2010 Jul; 168(4):1009-18. PubMed ID: 19699271
[TBL] [Abstract][Full Text] [Related]
15. Regulation and Function of AQP4 in the Central Nervous System.
Assentoft M; Larsen BR; MacAulay N
Neurochem Res; 2015 Dec; 40(12):2615-27. PubMed ID: 25630715
[TBL] [Abstract][Full Text] [Related]
16. The aquaporin-4 water channel as a potential drug target in neurological disorders.
Verkman AS; Smith AJ; Phuan PW; Tradtrantip L; Anderson MO
Expert Opin Ther Targets; 2017 Dec; 21(12):1161-1170. PubMed ID: 29072508
[TBL] [Abstract][Full Text] [Related]
17. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
Cayrol R; Saikali P; Vincent T
Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
[TBL] [Abstract][Full Text] [Related]
18. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
19. The role of AQP4 in neuromyelitis optica: More answers, more questions.
Yang X; Ransom BR; Ma JF
J Neuroimmunol; 2016 Sep; 298():63-70. PubMed ID: 27609277
[TBL] [Abstract][Full Text] [Related]
20. Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica.
Warth A
Med Hypotheses; 2009 Sep; 73(3):361-2. PubMed ID: 19398170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
